ad-rts-hil-12
Gene therapyexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2013 (NCT01703754)
Timeline
Indications
Mechanism of action
- Interleukin-12 subunit betaSupplementation
IL12B supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ad-rts-hil-12
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04006119 | Phase 2 | Jun 28, 2019 | Ziopharm |
| NCT03679754 | Phase 1 | Sep 30, 2018 | Ziopharm |
| NCT03636477 | Phase 1 | Jun 18, 2018 | Ziopharm |
| NCT03330197 | Phase 1 | Sep 26, 2017 | Ziopharm |
| NCT02423902 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2015 | Ziopharm |
| NCT01703754 | Phase 2 | Mar 1, 2013 | Ziopharm |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ziopharm | For profit | 6 | 6 | 2 | 2013 |
1 organizations
Page 1 / 1